Comparison of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the primary prevention of myocardial infarction in hypertensive patients

被引：6
|
作者：
Baer, JT
Sauer, WH
Berlin, JA
Kimmel, SE
机构：
[1] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Med, Div Cardiovasc, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Dept Med, Ctr Educ & Res Theraeut, Philadelphia, PA 19104 USA
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2004年 / 94卷 / 04期
关键词：
D O I：
10.1016/j.amjcard.2004.04.063
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers have slightly different mechanisms of action. As such, it has been hypothesized that these 2 classes of medications differ in their ability to prevent myocardial infarction. In the present case-control study, we found no difference between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the primary prevention of nonfatal myocardial infarction among patients with hypertension. (C) 2004 by Excerpta Medica, Inc.
引用
收藏
页码：479 / 481
页数：3
相关论文
共 50 条
  • [41] Association Between Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Suicide
    Mamdani, Muhammad
    Gomes, Tara
    Greaves, Simon
    Manji, Selina
    Juurlink, David N.
    Tadrous, Mina
    Kennedy, Sidney H.
    Antoniou, Tony
    JAMA NETWORK OPEN, 2019, 2 (10)
  • [42] The Role of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Postangioplasty Restenosis
    Liu, Ying
    Carrey, Zev
    Aronow, Wilbert S.
    Alaie, Daruish
    Petrillo, Richard L.
    Frishman, William H.
    AMERICAN JOURNAL OF THERAPEUTICS, 2015, 22 (04) : e107 - e114
  • [43] Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in clinical practice
    Barrios, Vivencio
    Coca, Antonio
    Escobar, Carlos
    Enrique, Rosa
    Miguel Rincon, Luis
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2012, 10 (02) : 159 - 166
  • [44] The Different Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Mortality
    Mourad, Jean-Jacques
    MAYO CLINIC PROCEEDINGS, 2016, 91 (07) : 972 - 972
  • [45] Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers in the Treatment of Hypertension
    Benenson, Irina
    JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2022, 18 (05): : 586 - 587
  • [46] Hyperkalemia Associated with Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
    Raebel, Marsha A.
    CARDIOVASCULAR THERAPEUTICS, 2012, 30 (03) : e156 - e166
  • [47] Angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, and risk of appendicitis
    Mukamal, Kenneth J.
    Ghimire, Sanjay
    Pandey, Rudra
    Fiarman, Gale S.
    Gautam, Shiva
    ANNALS OF EPIDEMIOLOGY, 2012, 22 (10) : 747 - 750
  • [48] Melanoma incidence and exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers
    Koomen, E. R.
    Herings, R. M. C.
    Guchelaar, H. J.
    Nijsten, T.
    CANCER EPIDEMIOLOGY, 2009, 33 (05) : 391 - 395
  • [49] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high vascular risk
    Potier, Louis
    Roussel, Ronan
    Elbez, Yedid
    Marre, Michel
    Zeymer, Uwe
    Reid, Christopher M.
    Ohman, Magnus
    Eagle, Kim A.
    Bhatt, Deepak L.
    Steg, Philippe Gabriel
    HEART, 2017, 103 (17) : 1339 - 1346
  • [50] Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers - A meta-analysis
    Healey, JS
    Baranchuk, A
    Crystal, E
    Morillo, CA
    Garfinkle, M
    Yusuf, S
    Connolly, SJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (11) : 1832 - 1839
12345